Neuland Laboratories Ltd (nse:NEULANDLAB) Share Price

Company Profile

Business description
Neuland Laboratories Ltd is engaged in the manufacturing and selling of bulk drugs and caters to both the domestic and international markets. It is an API contract development and manufacturing organization (CDMO), supporting biotechnology and pharmaceutical companies in the design, development, and manufacturing of complex active pharmaceutical ingredients (APIs). The company develops small molecules and peptides for clinical trials and beyond, with the capacity to scale up through every stage of the product lifecycle to commercial manufacturing. Geographically, the group derives maximum revenue from its customers in India, followed by Europe, the USA and North America, and the Rest of the world.
Contact
Road No. 82, Jubilee Hills
Plot No. 573A-III, Phoenix IVY Building
11th Floor (5th Office Level)
HyderabadTG500033
IND
T: +91 4067611600
https://www.neulandlabs.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
3,304

Recommended

From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.

Malik Ahmed Khan, CFA | 24 April 2026

Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.

Mark Taylor | 24 April 2026

ChatGPT and large language models should be a tailwind for this company.

Simonelle Mody | 24 April 2026

Index	Last price	Change	% Change
All Ordinaries	8,973.80	51.60	-0.57%
CAC 40	8,227.32	70.89	0.87%
DAX 40	24,155.45	39.45	-0.16%
Dow JONES (US)	49,310.32	179.71	-0.36%
FTSE 100	10,457.01	19.45	-0.19%
HKSE	25,769.86	145.34	-0.56%
NASDAQ	24,438.50	219.06	-0.89%
Nikkei 225	59,343.40	203.17	0.34%
NZX 50 Index	12,886.42	1.49	0.01%
S&P 500	7,108.40	29.50	-0.41%
S&P/ASX 200	8,750.60	48.00	-0.55%
SSE Composite Index	4,074.99	18.26	-0.45%